Company
Investment-firm
Financing round
General
About Company
Related to
Alexandria Real Estate Equities
Alexandria Real Estate Equities, Inc. is the largest and leading provider of real estate to the life science industry.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies147
venBio Partners
venBio is a life sciences investment firm that partners with industry leaders to develop groundbreaking medicines.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Torrey Pines Investment
San Diego venture capital firm investing in life science, biotech, and pharma.
Sector
Subsector
Location
count Of Investments
count Of Exists
Primer Capital
Primer Capital is a venture capital firm in Moscow City that focuses on investing in biotech and medical companies.
Sector
Subsector
Keywords
Location
count Of Investments
Coastview Capital
Coastview Capital, LLC is a venture capital firm that specialises in investing in life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Financials
Investments29
Radiant Biotherapeutics
Radiant is a biotech company advancing multi-specificity in biotechnology.
Sector
Subsector
Keywords
total rounds
total raised
Tiamat Sciences
Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors.
Sector
Subsector
Location
total rounds
total raised
ImCheck Therapeutics
ImCheck Therapeutics designs immunotherapy antibodies targeting butyrophilins and γ9δ2 T cells.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits8
TARA Biosystems
TARA Biosystems uses human biology and data to revolutionize cardiac drug discovery.
Sector
Subsector
Keywords
Location
total rounds
total raised
Vtesse
Vtesse is a rare disease company that develops drugs for severe and life-threatening diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Vividion Therapeutics
Vividion is a biotechnology company that develops drug discovery platform.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
People
Founders1
Joel Marcus
Joel Marcus is the Executive Chairman of the Board of Directors and Founder of Alexandria Real Estate Equities, Inc. (NYSE:ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations. Joel co-founded Alexandria in 1994 as a garage startup with a business plan, and $19 million in Series capital and has led its growth into a publicly traded, investment-grade REIT with a total market capitalization of approximately $18 billion and dominant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland and Research Triangle. Joel also founded and leads Alexandria Venture Investments, the company’s strategic venture capital arm, which focuses on novel, breakthrough discoveries in biopharmaceuticals, diagnostics, research tools, agtech, digital health, and technology. In 2011, Joel co-founded the renowned Alexandria Summit, an invitation-only gathering of the world’s foremost visionaries from the biopharmaceutical, medical, academic, financial, philanthropic, advocacy and government communities, to address the most critical global healthcare challenges. Prior to co-founding Alexandria, Joel had an extensive legal career specializing in corporate finance and capital markets, venture capital, and mergers and acquisitions, with a unique expertise in the biopharmaceutical industry. Joel was also a practicing Certified Public Accountant and Tax Manager with Arthur Young & Co., where he focused on the financing and taxation of REITs. Joel was one of the original architects and co-founders of Accelerator Life Science Partners, for which he serves on the board of directors. Mr. Marcus also serves on the boards of Applied Therapeutics Inc., Boragen Inc., Frequency Therapeutics, Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), MeiraGTx Holdings plc (NASDAQ:MGTX), and Yumanity Therapeutics; the Foundation for the National Institutes of Health (FNIH), MassBio, and Scripps Research; and the Emily Krzyzewski Center, the National September 11 Memorial & Museum, the Navy SEAL Foundation, the Partnership for New York City, and Robin Hood. Additionally, he is a member of the MIT Corporation Visiting Committee for the Department of Biology. Joel is a recipient of the EY Entrepreneur Of The Year Award (Los Angeles – Real Estate). Joel completed his undergraduate and Juris Doctor degrees at the University of California, Los Angeles.
current job
Joel Marcus
Employee Profiles6
Liz Henderson Doll
Senior Director - Asset Services
Dean A. Shigenaga
Co-President & Chief Financial Officer
Peter M. Moglia
Co-Chief Executive Officer & Co-Chief Investment Officer